Protocol for a phase 3, active (warfarin) controlled, randomized, double-blind, parallel-arm study to evaluate efficacy and safety of apixaban in preventing stroke and systemic embolism in patients with nonvalvular atrial fibrillation

Στεφανίδης, Ιωάννης Λ.

2015

free

Πανεπιστήμιο Θεσσαλίας. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής.

Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International